Taysha Gene Therapies, Inc.

TSHA · NASDAQ

Taysha Gene Therapies, Inc.TSHA · NASDAQ

Regular Market · Oct 30, 08:00 PM

$4.13-$0.09 -2.13%

After Hours $4.32 +$0.19 +4.50%

Oct 30, 09:14 PM

High: —
Low: —
Volume: —

Loading chart…

Ask Alva about TSHA

Taysha Gene Therapies, Inc.

TSHA · Biotechnology

4.13 USD

-0.09 (-2.13%)

At Close

4.32 USD

+0.19 (+4.50%)

After hours

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Taysha Gene Therapies, Inc.

TSHA · NASDAQ

At Close

4.13 USD

-0.09 (-2.13%)

After hours 4.32 USD +0.19 (+4.50%)

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Unusual Price Movement

TSHA rose against a broad risk-off market without a dated company catalyst

TSHA gained 4.8% while the S&P 500 and Nasdaq sold off sharply and volatility rose. The stock also outperformed its closest Rett gene-therapy peer, Neurogene, which fell on the day; no company news behind it was identified. The move was light-volume and remains unexplained.

Unusual Price Movement

TSHA rose against a broad risk-off market without a dated company catalyst

Ask Alva anything. @ for context, / for skills

Ask Alva about TSHA

TSHA rose against a broad risk-off market without a dated company catalyst ⓘ

TSHA rose against a broad risk-off market without a dated company catalyst ⓘ

TSHA rose against a broad risk-off market without a dated company catalyst

TSHA rose against a broad risk-off market without a dated company catalyst